Beneficial effects of Saccharomyces boulardii CNCM I-745 on clinical disorders associated with intestinal barrier disruption

References

• KönigJWellsJCaniPDHuman intestinal barrier function in health and diseaseClin Transl Gastroenterol2016710e19627763627
   PubMed Web of Science ®Google Scholar
• LechugaSIvanovAIDisruption of the epithelial barrier during intestinal inflammation: Quest for new molecules and mechanismsBiochim Biophys Acta18642017711831194
   Google Scholar
• KatoTHondaYKuritaYLubiprostone improves intestinal permeability in humans, a novel therapy for the leaky gut: a prospective randomized pilot study in healthy volunteersPLoS One2017124e017562628410406
   PubMed Web of Science ®Google Scholar
• CzeruckaDDahanSMograbiBRossiBRampalPSaccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cellsInfect Immun200068105998600410992512
   PubMed Web of Science ®Google Scholar
• OdenwaldMATurnerJRIntestinal permeability defects: is it time to treat?Clin Gastroenterol Hepatol20131191075108323851019
   PubMed Web of Science ®Google Scholar
• GroschwitzKRHoganSPIntestinal barrier function: Molecular regulation and disease pathogenesisJ Allergy Clin Immunol20091241320 quiz 21–2219560575
   PubMed Web of Science ®Google Scholar
• JandhyalaSMTalukdarRSubramanyamCVuyyuruHSasikalaMNageshwar ReddyDRole of the normal gut microbiotaWorld J Gastroenterol201521298787880326269668
   PubMed Web of Science ®Google Scholar
• Rajilić-StojanovićMSmidtHde VosWMDiversity of the human gastrointestinal tract microbiota revisitedEnviron Microbiol2007992125213617686012
   PubMed Web of Science ®Google Scholar
• FreterRBricknerHFeketeJVickermanMMCareyKESurvival and implantation of Escherichia coli in the intestinal tractInfect Immun19833926867036339389
   PubMed Web of Science ®Google Scholar
• KamadaNChenGYInoharaNNúñezGControl of pathogens and pathobionts by the gut microbiotaNat Immunol201314768569023778796
   PubMed Web of Science ®Google Scholar
• UkenaSNSinghADringenbergUProbiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrityPLoS One2007212e130818074031
   PubMed Web of Science ®Google Scholar
• Garcia-GutierrezEMayerMJCotterPDNarbadAGut microbiota as a source of novel antimicrobialsGut Microbes201860121
   Google Scholar
• SorgJASonensheinALBile salts and glycine as cogerminants for Clostridium difficile sporesJ Bacteriol200819072505251218245298
   PubMed Web of Science ®Google Scholar
• PengLLiZRGreenRSHolzmanIRLinJButyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayersJ Nutr200913991619162519625695
   PubMed Web of Science ®Google Scholar
• JohanssonMESjövallHHanssonGCThe gastrointestinal mucus system in health and diseaseNat Rev Gastroenterol Hepatol201310635236123478383
   PubMed Web of Science ®Google Scholar
• JohanssonMEVPhillipsonMPeterssonJVelcichAHolmLHanssonGCThe inner of the two MUC2 mucin-dependent mucus layers in colon is devoid of bacteriaProc Natl Acad Sci USA200810539150641506918806221
   PubMed Web of Science ®Google Scholar
• MergaYCampbellBJRhodesJMMucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapyDig Dis201432447548324969297
   PubMed Web of Science ®Google Scholar
• TamuraAHayashiHImasatoMLoss of claudin-15, but not claudin-2, causes Na+ deficiency and glucose malabsorption in mouse small intestineGastroenterology2011140391392320727355
   PubMed Web of Science ®Google Scholar
• LeeSHIntestinal permeability regulation by tight junction: implication on inflammatory bowel diseasesIntest Res2015131111825691839
   PubMed Web of Science ®Google Scholar
• TercioloCDobricAOuaissiMSaccharomyces boulardii CNCM I-745 restores intestinal barrier integrity by regulation of E-cadherin recyclingJ Crohns Colitis2017118999101028333335
   PubMed Web of Science ®Google Scholar
• KimMAshidaHOgawaMYoshikawaYMimuroHSasakawaCBacterial interactions with the host epitheliumCell Host Microbe201081203520638639
   PubMed Web of Science ®Google Scholar
• AwadWHessCHessMPathogensEEnteric pathogens and their toxin-induced disruption of the intestinal barrier through alteration of tight junctions in chickensToxins (Basel)201792E6028208612
   PubMed Web of Science ®Google Scholar
• StierHBischoffSInfluence of Saccharomyces boulardii CNCM I-745 on the gut-associated immune systemClin Exp Gastroenterol2016926927927695355
   PubMedGoogle Scholar
• HillDAArtisDIntestinal bacteria and the regulation of immune cell homeostasisAnnu Rev Immunol20102862366720192812
   PubMed Web of Science ®Google Scholar
• LallèsJPIntestinal alkaline phosphatase: novel functions and protective effectsNutr Rev2014722829424506153
   PubMed Web of Science ®Google Scholar
• FörsterCTight junctions and the modulation of barrier function in diseaseHistochem Cell Biol20081301557018415116
   PubMed Web of Science ®Google Scholar
• GuttmanJAFinlayBBTight junctions as targets of infectious agentsBiochim Biophys Acta178820094832841
   Google Scholar
• KöhlerHSakaguchiTHurleyBPKaseBAReineckerHCMcCormickBASalmonella enterica serovar Typhimurium regulates intercellular junction proteins and facilitates transepithelial neutrophil and bacterial passageAm J Physiol Gastrointest Liver Physiol20072931G178G18717615177
   PubMed Web of Science ®Google Scholar
• ButsJPDe KeyserNEffects of Saccharomyces boulardii on intestinal mucosaDig Dis Sci20065181485149216838119
   PubMed Web of Science ®Google Scholar
• GraffSChaumeilJCBoyPLai-KuenRCharrueauCInfluence of pH conditions on the viability of Saccharomyces boulardii yeastJ Gen Appl Microbiol200854422122718802321
   PubMed Web of Science ®Google Scholar
• Edwards-IngramLGitshamPBurtonNGenotypic and physiological characterization of Saccharomyces boulardii, the Probiotic strain of Saccharomyces cerevisiaeAppl Environ Microbiol20077382458246717293506
   PubMed Web of Science ®Google Scholar
• FiettoJLAraújoRSValadãoFNMolecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardiiCan J Microbiol200450861562115467787
   PubMed Web of Science ®Google Scholar
• PardoSGalvagnoMACerruttiPStudies of viability and vitality after freezing of the probiotic yeast Saccharomyces boulardii: physiological preconditioning effectRev Iberoam Micol2009262155160 Spanish19631167
   PubMed Web of Science ®Google Scholar
• CarioEBarrier-protective function of intestinal epithelial Toll-like receptor 2Mucosal Immunol2008Suppl 1S62S6619079234
   PubMed Web of Science ®Google Scholar
• YuSGaoNCompartmentalizing intestinal epithelial cell Toll-like receptors for immune surveillanceCell Mol Life Sci201572173343335326001904
   PubMed Web of Science ®Google Scholar
• OppongGORapsinskiGJNewmanTNNishimoriJHBieseckerSGTükelÇEpithelial cells augment barrier function via activation of the Toll-like receptor 2/phosphatidylinositol 3-kinase pathway upon recognition of Salmonella enterica serovar typhimurium curli fibrils in the gutInfect Immun201381247848623208603
   PubMed Web of Science ®Google Scholar
• SzajewskaHGuarinoAHojsakIEuropean Society for Pediatric Gastroenterology, Hepatology, and NutritionUse of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for probiotics and prebioticsJ Pediatr Gastroenterol Nutr201458453153924614141
   PubMed Web of Science ®Google Scholar
• McFarlandLVSystematic review and meta-analysis of Saccharomyces boulardii in adult patientsWorld J Gastroenterol201016182202222220458757
   PubMed Web of Science ®Google Scholar
• MoréMISwidsinskiASaccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis – a reviewClin Exp Gastroenterol2015823725526316791
   PubMedGoogle Scholar
• BerkesJViswanathanVKSavkovicSDHechtGIntestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammationGut200352343945112584232
   PubMed Web of Science ®Google Scholar
• Ngendahayo MukizaCDubreuilJDEscherichia coli heat-stable toxin B impairs intestinal epithelial barrier function by altering tight junction proteinsInfect Immun20138182819282723716609
   PubMed Web of Science ®Google Scholar
• ShawkiAMcColeDFMechanisms of intestinal epithelial barrier dysfunction by adherent-invasive Escherichia coliCell Mol Gastroenterol Hepatol201731415028174756
   PubMed Web of Science ®Google Scholar
• Ugalde-SilvaPGonzalez-LugoONavarro-GarciaFTight junction disruption induced by type 3 secretion system effectors injected by enteropathogenic and enterohemorrhagic Escherichia coliFront Cell Infect Microbiol201668727606286
   PubMed Web of Science ®Google Scholar
• Shen-TuGKimHLiuMJohnson-HenryKCShermanPMProtein kinase C mediates enterohemorrhagic Escherichia coli O157:H7-induced attaching and effacing lesionsInfect Immun20148241648165624491575
   PubMed Web of Science ®Google Scholar
• DahanSDalmassoGImbertVPeyronJFRampalPCzeruckaDSaccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cellsInfect Immun200371276677312540556
   PubMed Web of Science ®Google Scholar
• WuXVallanceBABoyerLSaccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factorsAm J Physiol Gastrointest Liver Physiol20082941G295G30618032474
   PubMed Web of Science ®Google Scholar
• ButsJPDekeyserNStilmantCDelemESmetsFSokalESaccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits Escherichia coli endotoxin by dephosphorylationPediatr Res2006601242916690953
   PubMed Web of Science ®Google Scholar
• HoyBGeppertTBoehmMDistinct roles of secreted HtrA proteases from gram-negative pathogens in cleaving the junctional protein and tumor suppressor E-cadherinJ Biol Chem201228713101151012022337879
   PubMed Web of Science ®Google Scholar
• MumyKLChenXKellyCPMcCormickBASaccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling eventsAm J Physiol Gastrointest Liver Physiol20082943G599G60918032477
   PubMed Web of Science ®Google Scholar
• MartinsFSDalmassoGArantesRMInteraction of Saccharomyces boulardii with Salmonella enterica serovar typhimurium protects mice and modifies T84 cell response to the infectionPLoS One201051e892520111723
   PubMed Web of Science ®Google Scholar
• MartinsFSVieiraATElianSDInhibition of tissue inflammation and bacterial translocation as one of the protective mechanisms of Saccharomyces boulardii against Salmonella infection in miceMicrobes Infect201315427027923376166
   PubMed Web of Science ®Google Scholar
• TiagoFCMartinsFSSouzaELAdhesion to the yeast cell surface as a mechanism for trapping pathogenic bacteria by Saccharomyces probioticsJ Med Microbiol201261Pt 91194120722580913
   PubMed Web of Science ®Google Scholar
• Pontier-BresRProdonFMunroPModification of Salmonella typhimurium motility by the probiotic yeast strain Saccharomyces boulardiiPLoS One201273e3379622442723
   PubMed Web of Science ®Google Scholar
• Pontier-BresRMunroPBoyerLSaccharomyces boulardii modifies Salmonella typhimurium traffic and host immune responses along the intestinal tractPLoS One201498e10306925118595
   PubMed Web of Science ®Google Scholar
• SchmidtEKellySMvan der WalleCFTight junction modulation and biochemical characterisation of the zonula occludens toxin C-and N-terminiFEBS Lett2007581162974298017553496
   PubMed Web of Science ®Google Scholar
• CzeruckaDRampalPEffect of Saccharomyces boulardii on cAMP- and Ca2+ -dependent Cl− secretion in T84 cellsDig Dis Sci199944112359236810573387
   PubMed Web of Science ®Google Scholar
• CzeruckaDNanoJLBernasconiPRampalPResponse to cholera toxin of 2 epithelial intestinal cell lines. Effect of Saccharomyces boulardiiGastroenterol Clin Biol1989134383387 French2544474
   PubMedGoogle Scholar
• BrandãoRLCastroIMBambirraEAIntracellular signal triggered by cholera toxin in Saccharomyces boulardii and Saccharomyces cerevisiaeAppl Environ Microbiol19986425645689464394
   PubMed Web of Science ®Google Scholar
• TafazoliFZengCQEstesMKMagnussonKESvenssonLNSP4 enterotoxin of rotavirus induces paracellular leakage in polarized epithelial cellsJ Virol20017531540154611152526
   PubMed Web of Science ®Google Scholar
• BuccigrossiVLaudieroGRussoCChloride secretion induced by rotavirus is oxidative stress-dependent and inhibited by Saccharomyces boulardii in human enterocytesPLoS One201496e9983024918938
   PubMed Web of Science ®Google Scholar
• SwidsinskiALoening-BauckeVKirschSDoerffelYFunctional biostructure of colonic microbiota (Central fermenting area, germinal stock area and separating mucus layer) in healthy subjects and patients with diarrhea treated with Saccharomyces boulardiiGastroentérologie Clinique et Biologique201034Suppl 1S79S92 French20889010
   PubMedGoogle Scholar
• BinZYa-ZhengXZhao-HuiDBoCLi-RongJVandenplasYThe efficacy of Saccharomyces boulardii CNCM I-745 in addition to standard Helicobacter pylori eradication treatment in childrenPediatr Gastroenterol Hepatol Nutr2015181172225866729
   PubMedGoogle Scholar
• KabbaniTAPallavKDowdSEProspective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteersGut Microbes201781173227973989
   PubMed Web of Science ®Google Scholar
• JumpRLClostridium difficile infection in older adultsAging Health20139440341424955106
   PubMedGoogle Scholar
• NusratAvon Eichel-StreiberCTurnerJRVerkadePMadaraJLParkosCAClostridium difficile toxins disrupt epithelial barrier function by altering membrane microdomain localization of tight junction proteinsInfect Immun20016931329133611179295
   PubMed Web of Science ®Google Scholar
• HechtGPothoulakisCLaMontJTMadaraJLClostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayersJ Clin Invest1988825151615243141478
   PubMed Web of Science ®Google Scholar
• BeaugerieLFlahaultABarbutFStudy GroupAntibiotic-associated diarrhoea and Clostridium difficile in the communityAliment Pharmacol Ther200317790591212656693
   PubMed Web of Science ®Google Scholar
• MassotJSanchezOCouchyRAstoinJParodiALBacterio-pharmacological activity of Saccharomyces boulardii in clindamycin-induced colitis in the hamsterArzneimittelforschung19843477947976541916
   PubMed Web of Science ®Google Scholar
• ToothakerRDElmerGWPrevention of clindamycin-induced mortality in hamsters by Saccharomyces boulardiiAntimicrob Agents Chemother19842645525566517545
   PubMed Web of Science ®Google Scholar
• CorthierGDubosFDucluzeauRPrevention of Clostridium difficile induced mortality in gnotobiotic mice by Saccharomyces boulardiiCan J Microbiol198632118948963815159
   PubMed Web of Science ®Google Scholar
• ElmerGWMcFarlandLVSuppression by Saccharomyces boulardii of toxigenic Clostridium difficile overgrowth after vancomycin treatment in hamstersAntimicrob Agents Chemother19873111291313566236
   PubMed Web of Science ®Google Scholar
• ButsJPBernasconiPVaermanJPDiveCStimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardiiDig Dis Sci19903522512562302983
   PubMed Web of Science ®Google Scholar
• CastagliuoloILaMontJTNikulassonSTPothoulakisCSaccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileumInfect Immun19966412522552328945570
   PubMed Web of Science ®Google Scholar
• CastagliuoloIRieglerMFValenickLLaMontJTPothoulakisCSaccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosaInfect Immun19996713023079864230
   PubMed Web of Science ®Google Scholar
• SougioultzisSSimeonidisSBhaskarKRSaccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expressionBiochem Biophys Res Commun20063431697616529714
   PubMed Web of Science ®Google Scholar
• HalpernMDDenningPWThe role of intestinal epithelial barrier function in the development of NECTissue Barriers201531–2e100070725927016
   PubMedGoogle Scholar
• RodríguezJMMurphyKStantonCThe composition of the gut microbiota throughout life, with an emphasis on early lifeMicrob Ecol Health Dis2015262605025651996
   PubMed Web of Science ®Google Scholar
• Gomez de AgüeroMGanal-VonarburgSCFuhrerTThe maternal microbiota drives early postnatal innate immune developmentScience201635162791296130226989247
   PubMed Web of Science ®Google Scholar
• DigiulioDBRomeroRAmoganHPMicrobial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigationPLoS One200838e305618725970
   PubMed Web of Science ®Google Scholar
• FlassTTongSFrankDNIntestinal lesions are associated with altered intestinal microbiome and are more frequent in children and young adults with cystic fibrosis and cirrhosisPLoS One2015102e011696725658710
   PubMed Web of Science ®Google Scholar
• JiménezEFernándezLMarínMLIsolation of commensal bacteria from umbilical cord blood of healthy neonates born by cesarean sectionCurr Microbiol200551427027416187156
   PubMed Web of Science ®Google Scholar
• AjslevTAAndersenCSGamborgMSørensenTIJessTChildhood overweight after establishment of the gut microbiota: the role of delivery mode, pre-pregnancy weight and early administration of antibioticsInt J Obes (Lond)201135452252921386800
   PubMed Web of Science ®Google Scholar
• YassourMVatanenTSiljanderHXavierRJDIABIMMUNE Study GroupNatural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stabilitySci Transl Med20168343343ra81
   PubMed Web of Science ®Google Scholar
• JohnsonCCOwnbyDRThe infant gut bacterial microbiota and risk of pediatric asthma and allergic diseasesTransl Res2017179607027469270
   PubMed Web of Science ®Google Scholar
• BerdingKDonovanSMDiet can impact microbiota composition in children with autism spectrum disorderFrontiers in neuroscience201812
   Web of Science ®Google Scholar
• JakaitisBMDenningPWHuman breast milk and the gastrointestinal innate immune systemClin Perinatol201441242343524873841
   PubMed Web of Science ®Google Scholar
• WestCERenzHJenmalmMCThe gut microbiota and inflammatory noncommunicable diseases: associations and potentials for gut microbiota therapiesJournal of Allergy and Clinical Immunology201511135131325567038
   PubMed Web of Science ®Google Scholar
• SjögrenYMTomicicSLundbergAInfluence of early gut microbiota on the maturation of childhood mucosal and systemic immune responsesClin Exp Allergy200939121842185119735274
   PubMed Web of Science ®Google Scholar
• RoundJLMazmanianSKInducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiotaProc Natl Acad Sci USA201010727122041220920566854
   PubMed Web of Science ®Google Scholar
• DemirelGErdeveOCelikIHDilmenUSaccharomyces boulardii for prevention of necrotizing enterocolitis in preterm infants: a randomized, controlled studyActa Paediatrica201310212e560e56524028629
   PubMed Web of Science ®Google Scholar
• DrosteJHWieringaMHWeylerJJNelenVJVermeirePAVan BeverHPDoes the use of antibiotics in early childhood increase the risk of asthma and allergic disease?Clin Exp Allergy2000301115481553
   Web of Science ®Google Scholar
• OngM-SUmetsuDTMandlKDConsequences of antibiotics and infections in infancy: bugs, drugs, and wheezingAnn Allergy Asthma Immunol20141125441445.e124631182
   PubMed Web of Science ®Google Scholar
• BaileyLCForrestCBZhangPRichardsTMLivshitsADeRussoPAAssociation of antibiotics in infancy with early childhood obesityJAMA Pediatr2014168111063106925265089
   PubMed Web of Science ®Google Scholar
• CukrowskaBSowińskaABierłaJBCzarnowskaERybakAGrzybowska-ChlebowczykUIntestinal epithelium, intraepithelial lymphocytes and the gut microbiota - Key players in the pathogenesis of celiac diseaseWorld J Gastroenterol201723427505751829204051
   PubMed Web of Science ®Google Scholar
• WestCERenzHJenmalmMCin-FLAME Microbiome Interest GroupThe gut microbiota and inflammatory noncommunicable diseases: associations and potentials for gut microbiota therapiesJ Allergy Clin Immunol20151351313 quiz 1425567038
   PubMed Web of Science ®Google Scholar
• BjörksténBSeppEJulgeKVoorTMikelsaarMAllergy development and the intestinal microflora during the first year of lifeJ Allergy Clin Immunol2001108451652011590374
   PubMed Web of Science ®Google Scholar
• HarbisonJERoth-SchulzeAJBarrySCGut microbiome dysbiosis and increased intestinal permeability in Australian children with islet autoimmunity and type 1 diabetesDiabetes201867Suppl 1230-OR2300
   Web of Science ®Google Scholar
• Leiva-GeaISánchez-AlcoholadoLMartín-TejedorBGut microbiota differs in composition and functionality between children with type 1 diabetes and MODY2 and healthy control subjects: a case-control studyDiabetes Care201841112385239530224347
   PubMed Web of Science ®Google Scholar
• LiXAtkinsonMAThe role for gut permeability in the pathogenesis of type 1 diabetes–a solid or leaky concept?Pediatr Diabetes201516748549226269193
   PubMed Web of Science ®Google Scholar
• MaffeisCMartinaACorradiMAssociation between intestinal permeability and faecal microbiota composition in Italian children with beta cell autoimmunity at risk for type 1 diabetesDiabetes Metab Res Rev201632770070926891226
   PubMed Web of Science ®Google Scholar
• AbrahamssonTRJakobssonHEAnderssonAFBjörksténBEngstrandLJenmalmMCLow diversity of the gut microbiota in infants with atopic eczemaJ Allergy Clin Immunol20121292434440e1-e222153774
   PubMed Web of Science ®Google Scholar
• OzkanTBSahinEErdemirGBudakFEffect of Saccharomyces boulardii in children with acute gastroenteritis and its relationship to the immune responseJ Int Med Res200735220121217542407
   PubMed Web of Science ®Google Scholar
• CaetanoJAParamésMTBaboMJImmunopharmacological effects of Saccharomyces boulardii in healthy human volunteersInt J Immunopharmacol1986832452593733298
   PubMed Web of Science ®Google Scholar
• DelzenneNMNeyrinckAMCaniPDGut microbiota and metabolic disorders: how prebiotic can work?Br J Nutr2013109Suppl 2S81S8523360884
   PubMed Web of Science ®Google Scholar
• LiuLSteinleJJToll-like receptor 4 regulates insulin signal transduction in retinal Müller cellsGrowth Factors201735623423829490521
   PubMed Web of Science ®Google Scholar
• SzaboGGut–Liver axis in alcoholic liver diseaseGastroenterology20151481303625447847
   PubMed Web of Science ®Google Scholar
• MieleLValenzaVLa TorreGIncreased intestinal permeability and tight junction alterations in nonalcoholic fatty liver diseaseHepatology20094961877188719291785
   PubMed Web of Science ®Google Scholar
• BaumgartDCSandbornWJInflammatory bowel disease: clinical aspects and established and evolving therapiesLancet200736995731641165717499606
   PubMed Web of Science ®Google Scholar
• CosnesJGower-RousseauCSeksikPCortotAEpidemiology and natural history of inflammatory bowel diseasesGastroenterology201114061785179421530745
   PubMed Web of Science ®Google Scholar
• RajcaSGrondinVLouisEAlterations in the intestinal micro-biome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn’s diseaseInflamm Bowel Dis201420697898624788220
   PubMed Web of Science ®Google Scholar
• ChangJLeongRWWasingerVCIpMYangMPhanTGImpaired intestinal permeability contributes to ongoing bowel symptoms in patients with inflammatory bowel disease and mucosal healingGastroenterology20171533723731.e128601482
   PubMed Web of Science ®Google Scholar
• ZbarAPSimopoulosCKarayiannakisAJCadherins: an integral role in inflammatory bowel disease and mucosal restitutionJ Gastroenterol200439541342115175938
   PubMed Web of Science ®Google Scholar
• BourreilleACadiotGLe DreauGFLORABEST Study GroupSaccharomyces boulardii does not prevent relapse of Crohn’s diseaseClin Gastroenterol Hepatol201311898298723466709
   PubMed Web of Science ®Google Scholar
• Garcia VilelaEDe Lourdes De Abreu FerrariMOswaldo da Gama TorresHInfluence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn’s disease in remissionScand J Gastroenterol200843784284818584523
   PubMed Web of Science ®Google Scholar
• CanoniciASiretCPellegrinoESaccharomyces boulardii improves intestinal cell restitution through activation of the α2β1 integrin collagen receptorPLoS One201163e1842721483797
   PubMed Web of Science ®Google Scholar
• CanoniciAPellegrinoESiretCSaccharomyces boulardii improves intestinal epithelial cell restitution by inhibiting αvβ5 integrin activation statePLoS One201279e4504723028753
   PubMed Web of Science ®Google Scholar
• LovellRMFordACGlobal prevalence of and risk factors for irritable bowel syndrome: a meta-analysisClin Gastroenterol Hepatol2012107712721.e422426087
   PubMed Web of Science ®Google Scholar
• MearinFBeLChangLBowel disordersGastroenterology2016150613931407
   Web of Science ®Google Scholar
• PicheTBarbaraGAubertPImpaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediatorsGut200958219620118824556
   PubMed Web of Science ®Google Scholar
• Bertiaux-VandaëleNYoumbaSBBelmonteLThe expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtypeAm J Gastroenterol2011106122165217322008894
   PubMed Web of Science ®Google Scholar
• AbbasZYakoobJJafriWCytokine and clinical response to Saccharomyces boulardii therapy in diarrhea-dominant irritable bowel syndrome: a randomized trialEur J Gastroenterol Hepatol201426663063924722560
   PubMed Web of Science ®Google Scholar
• JumpertzRLeDSTurnbaughPJEnergy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humansAm J Clin Nutr2011941586521543530
   PubMed Web of Science ®Google Scholar
• ZhangYJLiSGanRYZhouTXuDPLiHBImpacts of gut bacteria on human health and diseasesInt J Mol Sci20151647493751925849657
   PubMed Web of Science ®Google Scholar
• ZinöckerMLindsethIThe western diet–microbiomehost interaction and its role in metabolic diseaseNutrients2018103E36529562591
   PubMed Web of Science ®Google Scholar
• GenserLPoitouCÉB-LAlteration of intestinal permeability: the missing link between gut microbiota modifications and inflammation in obesity?Med Sci (Paris)201632546146927225918
   PubMed Web of Science ®Google Scholar
• KimKAGuWLeeIAJohEHKimDHHigh fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathwayPLoS One2012710e4771323091640
   PubMed Web of Science ®Google Scholar
• HamiltonMKBoudryGLemayDGRaybouldHEChanges in intestinal barrier function and gut microbiota in high-fat diet-fed rats are dynamic and region dependentAm J Physiol Gastrointest Liver Physiol201530810G840G85125747351
   PubMed Web of Science ®Google Scholar
• EverardAMatamorosSGeurtsLDelzenneNMCaniPDSaccharomyces boulardii administration changes gut microbiota and reduces hepatic steatosis, low-grade inflammation, and fat mass in obese and type 2 diabetic db/db miceMBio201453e010110101424917595
   PubMed Web of Science ®Google Scholar
• SchnablBBrennerDAInteractions between the intestinal microbiome and liver diseasesGastroenterology201414661513152424440671
   PubMed Web of Science ®Google Scholar
• ChangBSangLWangYTongJWangBThe role of FOXO4 in the relationship between alcohol-induced intestinal barrier dysfunction and liver injuryInt J Mol Med201331356957623292333
   PubMed Web of Science ®Google Scholar
• KarahanNIşlerMKoyuAEffects of probiotics on methionine choline deficient diet-induced steatohepatitis in ratsTurk J Gastroenterol201223211012122706738
   PubMed Web of Science ®Google Scholar
• SchneiderSMGirard-PipauFFilippiJEffects of Saccharomyces boulardii on fecal short-chain fatty acids and microflora in patients on long-term total enteral nutritionWorld J Gastroenterol200511396165616916273644
   PubMed Web of Science ®Google Scholar
• FengYSunXYangHTeitelbaumDHDissociation of E-cadherin and beta-catenin in a mouse model of total parenteral nutrition: a mechanism for the loss of epithelial cell proliferation and villus atrophyJ Physiol2009587Pt 364165419064618
   PubMed Web of Science ®Google Scholar
• NazliAChanODobson-BelaireWNExposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocationPLoS Pathog201064e100085220386714
   PubMed Web of Science ®Google Scholar
• Villar-GarcíaJHernándezJJGüerri-FernándezREffect of probiotics (Saccharomyces boulardii) on microbial translocation and inflammation in HIV-treated patients: a double-blind, randomized, placebo-controlled trialJ Acquir Immune Defic Syndr201568325626325469528
   PubMed Web of Science ®Google Scholar
• Al-SadiRYeDBoivinMInterleukin-6 modulation of intestinal epithelial tight junction permeability is mediated by JNK pathway activation of claudin-2 genePLoS One201493e8534524662742
   PubMed Web of Science ®Google Scholar
• MutluEAKeshavarzianALosurdoJA compositional look at the human gastrointestinal microbiome and immune activation parameters in HIV infected subjectsPLoS Pathog2014102e100382924586144
   PubMed Web of Science ®Google Scholar
• CapaldoCTNusratACytokine regulation of tight junctionsBiochim Biophys Acta178820094864871
   Google Scholar
• Villar-GarcíaJGüerri-FernándezRMoyaAImpact of probi-otic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: a double-blind, randomised, placebo-controlled trialPLoS One2017124e017380228388647
   PubMed Web of Science ®Google Scholar
• BrevesGFaulKSchröderBHolstHCasparyWFSteinJApplication of the colon-simulation technique for studying the effects of Saccharomyces boulardii on basic parameters of porcine cecal microbial metabolism disturbed by clindamycinDigestion200061319320010773725
   PubMed Web of Science ®Google Scholar